tiprankstipranks
TipRanksTop Financial ExpertsInsidersClarence Patrick Machado

Clarence Patrick Machado Insider Profile

18 Followers
Clarence Patrick Machado, Director at Alumis Inc., holds 10.62K shares in Alumis Inc. (Ticker: ALMS), holds 66.16K shares in Medivation (Ticker: MDVN), holds ― shares in Rocket Pharmaceuticals (Ticker: RCKT).
See the Hottest Stocks Based on Insider Trading >
tipranks
Clarence Patrick Machado

Clarence Patrick Machado
Alumis Inc. (ALMS)
Director

Ranked #97,306 out of 108,921 Corporate Insiders

Profitable Transactions

38%
6 out of 16 Profitable Transactions

Average Return

-19.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$84M
98.11%
1.56%
0.19%
0.14%
0.00% Others
A breakdown of Clarence Patrick Machado's holdings
See the Top Stocks by Insiders

Insider Roles

Arbutus Biopharma
(ABUS)
Former 10% Owner
Arcus Biosciences
(RCUS)
Director
Xenon
(XENE)
Director
Alumis Inc.
(ALMS)
Director
+2 other positions
Roles that Clarence Patrick Machado holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
Arbutus Biopharma
(ABUS)
Rating:Informative Buy
Date:Oct 19, 2016 - Oct 19, 2017
Return:+113.60%
The most profitable trade made by Clarence Patrick Machado
See the Latest Stocks Traded by Insiders

Clarence Patrick Machado's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ALMS
Alumis Inc.
Jul 02, 2026
Director
Uninformative Buy
―
$117.85K
MDVN
Medivation
Sep 30, 2016
―
Uninformative Sell
―
$5.35M
RCKT
Rocket Pharmaceuticals
―
Director
―
―
ABUS
Arbutus Biopharma
Oct 19, 2016
Former 10% Owner
Informative Buy
―
$82.47M
SIOX
Sio Gene Therapies
Mar 19, 2019
―
Informative Buy
10.00M
$50.65M
ADVM
Adverum Biotechnologies
Dec 10, 2025
―
Uninformative Sell
―
$0.00
ECYT
Endocyte
Dec 21, 2018
―
Uninformative Sell
30.00K
$0.00
MYOV
Myovant Sciences
Jun 06, 2019
―
Informative Buy
20.00M
$1.10B
UROV
Urovant Sciences
Jun 19, 2019
―
Uninformative Buy
151.30K
$371.25M
TPTX
Turning Point Therapeutics
―
―
―
―
PRNB
Principia Biopharma
―
―
―
―
RCUS
Arcus Biosciences
Jun 12, 2026
Director
Uninformative Buy
―
$1.31M
XENE
Xenon
Jun 03, 2026
Director
Uninformative Buy
141.27K
$158.04K
SLRN
ACELYRIN, INC.
May 23, 2025
―
Uninformative Sell
―
$0.00
CMRX
Chimerix
Dec 29, 2015
―
Informative Buy
70.80K
$85.40K
SCYX
SCYNEXIS
Sep 16, 2016
Director
Informative Buy
117.60K
$0.00
List of latest transactions for each holding click on a transaction to see Clarence Patrick Machado's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Clarence Patrick Machado insider profile FAQ

What is the percentage of profitable transactions made by Clarence Patrick Machado?
The percentage of profitable transactions made by Clarence Patrick Machado is 38%.
    What is the average return per transaction made by Clarence Patrick Machado?
    The average return per transaction made by Clarence Patrick Machado is -19.40%.
      What stocks does Clarence Patrick Machado hold?
      Clarence Patrick Machado holds: ALMS, MDVN, RCKT, ABUS, SIOX, ADVM, ECYT, MYOV, UROV, TPTX, PRNB, RCUS, XENE, SLRN, CMRX, SCYX stocks.
        What was Clarence Patrick Machado’s latest transaction?
        Clarence Patrick Machado latest transaction was an Uninformative Buy of ―.
          What was Clarence Patrick Machado's most profitable transaction?
          Clarence Patrick Machado’s most profitable transaction was an Informative Buy of ABUS stock on October 19, 2016. The return on the trade was 113.60%.
            What is Clarence Patrick Machado's role in Alumis Inc.?
            Clarence Patrick Machado's role in Alumis Inc. is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.